GSK plc (GSK.L)

LSE · Healthcare · Drug Manufacturers - General
1,842.50 GBp+0.85%As of 2026-11-22 · GBp
Last session low 1,833.00 GBpLast session high 1,860.50 GBp
52-week low 1,690.00 GBp52-week high 2,282.00 GBp
Market cap (USD)
$96.63B
Sector
Healthcare
P/E (TTM)
17.2x
Dividend yield
3.69%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in GBp.

IndicatorValueReading
RSI (14)47.1In the neutral range (30 to 70)
MACD (12, 26, 9)3.98Below its signal line (10.66); histogram -6.67
Bollinger %B (20, 2)28%Inside the bands (1,800.92 to 1,949.30)
SMA 201,875.11Price is 1.7% below
SMA 501,853.68Price is 0.6% below
SMA 2001,949.48Price is 5.5% below
ATR (20)2.59% of priceAverage true range per day
52-week position26%In the lower part of the 1,690.00 to 2,282.00 range

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments.

Insider filings, 90 days51 purchases (about 548K GBP) and no sales.
Latest fiscal yearEnded 2025-12-31: revenue of 32.67B GBP and an operating margin of 25.5%.

Also listed as GSK (NYSE)

More in Drug Manufacturers - General